key: cord-0922714-hv3h1fxn
authors: Yamamoto, Kei; Nagashima, Mami; Yoshida, Isao; Sadamasu, Kenji; Kurokawa, Masami; Nagashima, Maki; Kinoshita, Noriko; Kenji, Maeda; Takasaki, Jin; Teruya, Katsuji; Ohmagari, Norio
title: Does the SARS-CoV-2 rapid antigen test result correlate with the viral culture result?
date: 2021-05-12
journal: J Infect Chemother
DOI: 10.1016/j.jiac.2021.05.006
sha: b5a65aa925524a70dd0c3f69df89f7bf97888ab9
doc_id: 922714
cord_uid: hv3h1fxn

Rapid antigen tests (RATs) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have advantages over viral culture in terms of cost and rapidity of testing, but they have low sensitivity. In addition, RATs tend to be negative from approximately 11 days after symptom onset. To determine whether the antigen-negative state indicates a lack of infectiousness, we assessed the association between viral culture and RAT results. Viral culture, reverse transcription-quantitative polymerase chain reaction (RT-qPCR), and rapid antigen testing were performed on stored nasopharyngeal samples with threshold cycle values <30, based on previous RT-qPCR testing. SARS-CoV-2 was isolated by viral culture from nine samples (45%) and one sample (17%) with positive and negative RAT results, respectively. The RAT and viral culture results were both associated with the viral load level and their cutoffs were similar, but the associations were not statistically significant. RAT might be a useful indicator of infectiousness, which can be helpful to control infection. However, further studies with larger sample size are warranted to confirm this observation.

(2) drafting the article or revising it critically for important intellectual content: K.

Yamamoto, and M. Nagashima, I. Yoshida, K. Sadamasu, N. Ohmagari Immunochromatographic rapid antigen tests (RATs) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are simple to perform and have a relatively low cost but they have a low sensitivity [1] [2] [3] . A potential advantage of the low sensitivity of RATs is that they do not remain positive during the long period of low viral excretion after infectiousness has passed [4] . Espline ® SARS-CoV-2 (Fujirebio, Tokyo, Japan) was approved in Japan as a RAT for diagnosing COVID-19 on 13 May 2020, the first approval of this kit worldwide. Previous studies have shown that RATs have a low sensitivity at low viral load levels (67%), but a relatively high sensitivity (93%) at high viral load levels (>400 copies/test) [5] . In a previous study, we determined that the concordance with reverse transcription-quantitative polymerase chain reaction (RT-qPCR) in the early stage of COVID-19 (within 9 days after symptom onset) was 72% for positive and 100% for negative RAT results. Moreover, in samples with >10 3 copies/test (>85 copies/µL), the positive concordance was 85% [1] . We hypothesized the RAT results might be useful for determining whether an individual is still infectious during the convalescent phase when there is no fever and the virus is presumed to be no longer infectious. This study compared SARS-CoV-2 RAT results to viral culture results to test this hypothesis.

Stored nasal swab samples from COVID-19 patients admitted to our hospital between J o u r n a l P r e -p r o o f March 6 and June 14, 2020 were used in the study. The virus transport media were refrigerated within 24 h after sample collection and were further frozen at −80°C latest by 72 h after the refrigeration. We used 26 samples in virus transport media (universal transport media, Copan) that had previously been shown to have threshold cycle values less than 30 by RT-qPCR. We performed RT-qPCR, RAT (Espline ® SARS-CoV-2), and viral cultures with VeroE6 and VeroE6/TMPRSS2 cells [6] . VeroE6 and VeroE6/TMPRSS2 cells (JCRB1819) were cultured in 1 mL Dulbecco's modified eagle medium "Nissui" (D-MEM, Nissui Pharmaceutical Co., Ltd., Tokyo, Japan) containing 10% heat-inactivated fetal bovine serum (FBS) and 1% penicillin-streptomycin (MP Biomedicals, France). These cells with D-MEM (1 mL) were added to a 24-well plate and incubated for 72 h at 37°C with 5% CO 2 . Once the cells adhered to the base and monolayer culture was obtained in each well, the medium was replaced with 1 mL Eagle's minimum essential medium (Fujifilm, Japan) containing 2% FBS. Further, the wells were inoculated with 100 μL of each clinical specimen in a BSL3 laboratory. After Inc., Shiga, Japan) to confirm viral replication. RAT was performed using highly concentrated reagent for virus transport media. This study was approved by the ethical Although we were unable to show significant results due to the small sample size, there was an association between the viral load, RAT, and viral culture results, with an optimal cutoff value of 10 5 copies/mL, suggesting a strong association between the viral culture and RAT results. There have been few previous studies in which antigen testing and viral culture were performed simultaneously [3, 7] . Yamayoshi et al. [7] compared the RATs (including Espline ® SARS-CoV-2) and viral culture results on 18 nasopharyngeal samples. Of these, seven of eight RAT-positive samples (88%) and three of ten RAT-negative samples (30%) were positive on viral culture [7] . There were fewer samples that were positive based on viral culture in our study than in the study by Yamamoto et al. [1] because a higher proportion of the samples in our study were collected >9 days after symptom onset. Positive viral culture results are known to be associated with the number of days since the disease onset [8] . On the other hand, because the antigen test depends on the amount of nucleic acid as it captures nucleoproteins, the results of RAT and viral culture tended to strongly correlate with viral load and duration after the onset of symptoms, respectively, as shown in Figure 1 .

The freezing and thawing involved in the aliquoting process may also have contributed J o u r n a l P r e -p r o o f to the lower yield on viral culture in our study. Although results of the study by Yamamoto et al. [1] suggest that RATs could be used as a tool to screen for infectiousness, they did not report the relationship between the RAT and the viral culture results. In this study, specimens having Ct below 30 by earlier RT-PCR were used to secure a sufficient amount of virus for virus culture while excluding the possibility of sampling errors. Therefore, the stage of the disease was slightly biased toward the early stage, and one of the limitations was that we could not examine specimens with low viral load. Although our results did not differ significantly due to the small sample size, they suggest that RATs could be used as a tool to screen for infectiousness. If we can show this association, it may be useful for screening test in resource-limited facilities where tests such as nucleic acid amplification tests (NAATs) are not available and for determining viral remnants after infection that were found to be positive by NAATs. Further investigation is required to confirm the association between the RAT and viral culture results.

K.Y. has received research grants from Fujirebio, Inc., Mizuho Medy, Co., Ltd., and VisGene Inc., N.O. has received grants from Sanofi Pasteur and Eiken Chemical Co., 

Utility of the antigen test for coronavirus disease 2019: Factors influencing the prediction of the possibility of disease transmission

Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis

Evaluation of rapid antigen test for detection of SARS-CoV-2 virus

Rethinking COVID-19 test sensitivity -a strategy for containment

Japanese Ministry of Health, Labour and Welfare, Approval of in vitro diagnostics for the novel coronavirus infection

Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells

Comparison of rapid antigen tests for COVID-19

Duration of SARS-CoV-2 infectivity: When is it safe to discontinue isolation?